3.00% Convertible Senior Notes Due 2021
The Company also proposes to grant to the Underwriters an option to purchase up to an additional principal amount of securities set forth in Schedule I hereto to cover over-allotments (the “Option Securities”; the Option Securities, together with the Underwritten Securities, hereinafter called the “Securities”).
The Securities are convertible into shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company at the conversion price set forth on Schedule IV hereto.
(a) Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the purchase price set forth in Schedule I hereto the principal amount of the Securities set forth opposite such Underwriter’s name in Schedule II hereto.
(b)         Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company hereby grants an option to the several Underwriters to purchase, severally and not jointly, up to the principal amount of Option Securities set forth in Schedule I hereto at the same purchase price set forth in Schedule I hereto for the Underwritten Securities.
aggregate principal amount of Option Securities to be purchased by each Underwriter shall be the same percentage of the total aggregate principal amount of the Option Securities to be purchased by the several Underwriters as such Underwriter is purchasing of the Underwritten Securities, subject to such adjustments as you in your absolute discretion shall make to ensure that the Option Securities are not issued in minimum denominations of less than $1,000 or whole multiples thereof.
any other shares of Common Stock or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock; or publicly announce an intention to effect any such transaction, for a period of 60 days after the date of the Underwriting Agreement, provided, however, that the Company may (i) issue and sell Common Stock, or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock, pursuant to any employee stock option plan, incentive plan, stock ownership plan or dividend reinvestment plan of the Company in effect at the Execution Time or disclosed in the Final Prospectus, (ii) issue Common Stock issuable upon the conversion of securities outstanding at the Execution Time, (iii) file one or more registration statements on Form S-8, (iv) offer, issue and sell shares of Common Stock or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock in connection with any acquisition or strategic investment (including any joint venture, strategic alliance or partnership) as long as (x) the aggregate number of shares of Common Stock issued or issuable does not exceed 10% of the number of shares of Common Stock outstanding immediately after the issuance and sale of the Securities, and (y) each recipient of any such shares or other securities agrees to restrictions on the resale of securities that are consistent with the lock-up letters described in Section 6(j) hereof for the remainder of the 60-day restricted period or (v) on or after October 31, 2014, file a post-effective amendment to the Registration Statement.
If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased by such Underwriter or
Title: TESARO, Inc. 3.00% Convertible Senior Notes Due 2021
Principal amount of Underwritten Securities: $175,000,000.00
Purchase price (include accrued interest or amortization, if any): 97.00% of the principal amount thereof
Principal Amount of Option Securities: $26,250,000.00
Other provisions: The Securities are convertible, at the option of the holder, at any time prior to the close of business on the business day immediately preceding April 1, 2021 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2014, if the closing sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) in the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price of the Securities in effect on each applicable trading day; (2) during the five consecutive business-day period following any ten consecutive trading-day period in which the trading price per $1,000 principal amount of Securities for each such trading day was less than 98% of the closing sale price of the Company’s common stock on such date multiplied by the then-current conversion rate; or (3) upon the occurrence of specified corporate events.
The initial conversion rate will be 28.4627 shares of common stock per $1,000 principal amount of Securities (equivalent to a conversion price of approximately $35.13 per share), subject to adjustment.
74,375,000.00
11,156,250.00
65,625,000.00
9,843,750.00
17,500,000.00
2,625,000.00
8,750,000.00
1,312,500.00
8,750,000.00
1,312,500.00
175,000,000.00
26,250,000.00
$175,000,000 AGGREGATE PRINCIPAL AMOUNT OF
3.00% CONVERTIBLE SENIOR NOTES DUE 2021
3.00% Convertible Senior Notes due 2021 (the “Notes”).
$175.00 million aggregate principal amount of Notes (or $201.25 million, if the underwriters fully exercise their option to purchase additional Notes).
Annual Interest Rate:
3.00% per annum.
Interest Payment Dates:
Last Reported Sale Price of Common Stock on NASDAQ on September 23, 2014:
Approximately 35% above the NASDAQ Last Reported Sale Price of Common Stock.
Initial Conversion Price:
Approximately $35.13 per share.
28.4627 shares of the Issuer’s Common Stock per $1,000 principal amount of Notes.
The Issuer estimates that the net proceeds from this offering will be approximately $169.25 million (or $194.71 million if the underwriters fully exercise their option to purchase additional Notes), after deducting the underwriting discount and its estimated offering expenses.
The Issuer intends to use approximately $18.11 million of the net proceeds from this offering to fund the payment of the cost of the capped call transactions described below.
If the underwriters exercise their option to purchase additional Notes, the Issuer may use the net proceeds of the sale of the additional Notes to fund the payment of the cost of entering into additional capped call transactions and for the purposes described above.
If the underwriters exercise their option to purchase additional Notes, the Issuer may enter into additional capped call transactions with the hedge counterparties.
The Issuer’s entry into the capped call transactions, including the payment of the approximately $18.11 million premium therefor to the hedge counterparties (and the additional premium payable by the Issuer to the hedge counterparties if the Issuer enters into the additional capped call transactions described above), will result in a reduction to the Issuer’s additional paid-in capital, stockholders’ equity and total capitalization.
The following table sets forth the number of additional shares of Common Stock that will be added to the conversion rate per $1,000 principal amount of the Notes for each stock price and effective date set forth below:
Stock Price
$26.025
$30.00
$35.13
$40.00
$45.00
$50.00
$60.00
$80.00
$100.00
$125.00
$150.00
$200.00
9.9618
5.2721
2.7424
0.8162
0.5891
0.3341
9.9618
3.4663
1.5715
1.0801
0.7364
0.5309
0.3007
9.9618
1.3927
0.9487
0.6448
0.4649
0.2638
9.9618
7.8170
4.4332
3.5090
2.0026
1.1760
0.7939
0.5394
0.3901
0.2225
9.9618
7.4791
2.4002
1.6213
0.9178
0.6159
0.4212
0.3073
0.1771
9.9618
6.9821
2.3798
1.1396
0.6181
0.4184
0.2924
0.1270
9.9618
0.9651
0.5450
0.2984
0.2142
0.1556
0.1175
0.0700
9.9618
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
·                  If the stock price is greater than $200.00 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of the table above), no additional shares will be added to the conversion rate.
·                  If the stock price is less than $26.025 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of the table above), no additional shares will be added to the conversion rate.
Notwithstanding the foregoing, in no event will the conversion rate be increased pursuant to the provisions described in the Preliminary Prospectus Supplement under the caption “Description of the Notes—Adjustment to Conversion Rate upon Conversion upon a Make-Whole Adjustment Event” to exceed 38.4245 shares of common stock per $1,000 principal amount of Notes, subject to adjustment in the same manner as the conversion rate as set forth in the Preliminary Prospectus Supplement under the caption “Description of the Notes—Conversion of Notes—Conversion Rate Adjustments.”
The Convertible Notes will be convertible into shares of the common stock, $0.0001 par value (the “Common Stock”), of the Company.
